Hepatitis C Virus ECHO
Hepatitis C Virus ECHO
As the most common blood-borne infection and a leading cause of liver disease, failure, and cancer, hepatitis C virus (HCV) poses a major threat to the health of our communities. To address this, we are establishing an HCV ECHO to educate practitioners about the disease and provide evidence-based, interdisciplinary guidance for management and treatment using highly effective, direct-acting antivirals. Our team is made up of experts in HCV care delivery, including a hepatologist, a community-based pharmacist, an infectious diseases specialist, and a community health worker with more than 6 years of supporting uninsured patients who are diagnosed with chronic HCV (in rural and urban settings).
Our expert panel includes:
- Hopethe Baker MD, Hepatologist
- Victor Ankoma-sey MD, FACP, FAASLD, Gastroenterologist
- Dewayne Davidson PharmD, Pharmacist
- Raudel Bobadilla MPH, Community Health Worker
- Ludivina Hernandez CHW, Community Health Worker
Continuing medical education (CME) is available for free to attendees.
Treatment and testing resources are available to session registrants through the HCV Partner Portal.
Session recordings
Please check back for new content.
Session 37 – June 19, 2023
When HCV Treatment is Deffered
- Presented by: Hopethe Baker, MD
Session 36 – May 17, 2023
The National Hepatitis Elimination Plan
- Presented by: DeWayne Davidson, PharmD
Session 35 – April 17, 2023
HCV/HBV Co-infection
- Presented by: Hopethe Baker, MD